4dmedical Limited Stock Market Value
| FDMDF Stock | USD 2.35 0.50 27.03% |
| Symbol | 4DMedical |
4DMedical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to 4DMedical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of 4DMedical.
| 11/27/2025 |
| 12/27/2025 |
If you would invest 0.00 in 4DMedical on November 27, 2025 and sell it all today you would earn a total of 0.00 from holding 4DMedical Limited or generate 0.0% return on investment in 4DMedical over 30 days. 4DMedical is related to or competes with PolyNovo, CellaVision, Xvivo Perfusion, Sosei Group, Beijing Tong, GenSight Biologics, and Allergy Therapeutics. 4DMedical Limited operates as a medical technology company in Australia and the United States More
4DMedical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure 4DMedical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess 4DMedical Limited upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 13.75 | |||
| Information Ratio | 0.1125 | |||
| Maximum Drawdown | 85.06 | |||
| Value At Risk | (12.80) | |||
| Potential Upside | 19.83 |
4DMedical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for 4DMedical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as 4DMedical's standard deviation. In reality, there are many statistical measures that can use 4DMedical historical prices to predict the future 4DMedical's volatility.| Risk Adjusted Performance | 0.093 | |||
| Jensen Alpha | 1.62 | |||
| Total Risk Alpha | 0.1428 | |||
| Sortino Ratio | 0.1057 | |||
| Treynor Ratio | (1.30) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of 4DMedical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
4DMedical Limited Backtested Returns
4DMedical is abnormally volatile given 3 months investment horizon. 4DMedical Limited secures Sharpe Ratio (or Efficiency) of 0.12, which signifies that the company had a 0.12 % return per unit of price deviation over the last 3 months. We were able to break down twenty-seven different technical indicators, which can help you to evaluate if expected returns of 1.54% are justified by taking the suggested risk. Use 4DMedical Coefficient Of Variation of 839.88, risk adjusted performance of 0.093, and Mean Deviation of 5.68 to evaluate company specific risk that cannot be diversified away. 4DMedical holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -1.17, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning 4DMedical are expected to decrease by larger amounts. On the other hand, during market turmoil, 4DMedical is expected to outperform it. Use 4DMedical downside variance, rate of daily change, and the relationship between the maximum drawdown and skewness , to analyze future returns on 4DMedical.
Auto-correlation | -0.78 |
Almost perfect reverse predictability
4DMedical Limited has almost perfect reverse predictability. Overlapping area represents the amount of predictability between 4DMedical time series from 27th of November 2025 to 12th of December 2025 and 12th of December 2025 to 27th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of 4DMedical Limited price movement. The serial correlation of -0.78 indicates that around 78.0% of current 4DMedical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.78 | |
| Spearman Rank Test | -0.13 | |
| Residual Average | 0.0 | |
| Price Variance | 0.19 |
4DMedical Limited lagged returns against current returns
Autocorrelation, which is 4DMedical pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting 4DMedical's pink sheet expected returns. We can calculate the autocorrelation of 4DMedical returns to help us make a trade decision. For example, suppose you find that 4DMedical has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
4DMedical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If 4DMedical pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if 4DMedical pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in 4DMedical pink sheet over time.
Current vs Lagged Prices |
| Timeline |
4DMedical Lagged Returns
When evaluating 4DMedical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of 4DMedical pink sheet have on its future price. 4DMedical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, 4DMedical autocorrelation shows the relationship between 4DMedical pink sheet current value and its past values and can show if there is a momentum factor associated with investing in 4DMedical Limited.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in 4DMedical Pink Sheet
4DMedical financial ratios help investors to determine whether 4DMedical Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 4DMedical with respect to the benefits of owning 4DMedical security.